Aparna Nallagangula

Assistant Clinical Professor, Medicine - (Clinical Series Track)

Contact

(520) 626-6453
AHSC, Rm. 2301
nalla@arizona.edu

Licensure & Certification

Internal Medicine Certification, American Board of Internal Medicine (2019)
Medical Oncology Certification, American Board of Internal Medicine (2023)

Interests

Research

Advanced cutaneous malignancies, Immunotherapy

Teaching

Advanced cutaneous malignancies

Courses

No activities entered.

Scholarly Contributions

Journals/Publications

In, G. K., Nallagangula, A., Choi, J. S., Tachiki, L., Blackburn, M. J., Capone, S., Bollin, K. B., Reuben, D. Y., Shirai, K., Zhang-Nunes, S., Ragab, O., Terando, A., Hu, J. C., Lee, H., Bhatia, S., Chandra, S., Lutzky, J., & Gibney, G. T. (2022). Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma. Journal for immunotherapy of cancer, 10(5).
More info
Basal cell carcinoma (BCC) is the most common malignancy worldwide, yet the management of patients with advanced or metastatic disease is challenging, with limited treatment options. Recently, programmed death receptor 1 (PD-1) inhibition has demonstrated activity in BCC after prior Hedgehog inhibitor treatment.

Edit my profile